Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, September 03, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Precise Flow Measurement at Elevated Temperatures
Thursday, August 28, 2014
High temperature Atrato ultrasonic flowmeter from Titan Enterprises.

Syrris Launches New Atlas Cryo Reactor for Ultra-low Temperature Synthesis
Tuesday, August 19, 2014
The Company is pleased to announce the latest in a series of innovative new products released during 2014.

Whitehouse Scientific Sponsors Particulate Systems Analysis Conference 2014
Friday, August 08, 2014
12th PSA conference and exhibition in Manchester UK from 15 - 17 September 2014.

EasyFinder Online Selection Tool from Mettler Toledo
Friday, July 25, 2014
New tool helps customers find the perfect laboratory balances and scales with just a few clicks of their mouse.

High Performance Multi-Position Reaction Block
Tuesday, July 22, 2014
DrySyn MULTI heating blocks create a safer, cleaner and more efficient working environment.

Flexible Flow Meter Platform for OEM Product Development
Saturday, July 19, 2014
Hedgehog - An electronic development platform for OEM applications.

High Specification Ultra Safe Pressure Reactor
Tuesday, July 15, 2014
PressureSyn - New, 125ml working volume high pressure reactor from Asynt.

Mettler Toledo Launches New Differential Scanning Calorimeter DSC 2
Tuesday, July 08, 2014
The DSC utilizes an innovative patented DSC sensor with 120 thermocouples which guarantees unmatched sensitivity.

Bulgin Launches Premium, Vandal-Proof Piezo Switches
Thursday, July 03, 2014
New line of IP68 and IP69K rated piezo switches from Bulgin.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 906
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv